Sukhtian Ghiath M. - 27 May 2025 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role: Director, 10%+ Owner
Signature: /s/ Ghiath M. Sukhtian, By: Lawrence Kenyon, Attorney-in-Fact
Issuer symbol: OTLK
Transactions as of: 27 May 2025
Net transactions value: +$6,000,000
Form type: 4
Filing time: 28 May 2025, 17:20:21 UTC
Previous filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Owners (2)

Name	Relationship	Address	Signature	Signature date	CIK
Sukhtian Ghiath M.	Director, 10%+ Owner	7TH CIRCLE, ZAHRAN ST., ZAHRAN PLAZA BUILDING, 4TH FLOOR, AMMAN, JORDAN	/s/ Ghiath M. Sukhtian, By: Lawrence Kenyon, Attorney-in-Fact	28 May 2025	0001717441
GMS Ventures & Investments	Director, 10%+ Owner	C/O INTERTRUST CORP. SVCS. (CAYMAN) LTD., 190 ELGIN AVENUE GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS	/s/ GMS Ventures and Investments, By: Lawrence Kenyon, Attorney-in-Fact	28 May 2025	0001804598

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OTLK	Common Stock	Award	$6,000,000	+4,285,714	+46%	$1.40	13,552,359	27 May 2025	See footnote	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OTLK	Warrants (right to buy)	Award		+8,571,428			8,571,428	27 May 2025	Common Stock	8,571,428	$1.40	See footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired in an underwritten public offering, pursuant to which Outlook Therapeutics, Inc. (the "Issuer") sold shares of common stock, and, for each such share of common stock, accompanying warrants to purchase two shares of common stock, at a purchase price of $1.40 per share and accompanying warrant.
F2	These securities are held of record by GMS Ventures and Investments ("GMS Ventures"). Ghiath M. Sukhtian ("Ghiath Sukhtian"), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
F3	By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.